VTYX - CIK 0001851194
Ventyx Biosciences, Inc. has filed 495 documents with the SEC between 2021 and 2026. The most frequent type is insider trade (196 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| SCHEDULE 13G/A | - | 2026-05-14 | - |
| SCHEDULE 13G/A | - | 2026-05-14 | - |
| 15-12G | - | 2026-03-16 | - |
| EFFECT | - | 2026-03-06 | - |
| EFFECT | - | 2026-03-06 | - |
| SCHEDULE 13D/A | - | 2026-03-05 | - |
| Insider trade | 4 | 2026-03-04 | 2026-03-04 |
| Insider trade | 4 | 2026-03-04 | 2026-03-04 |
| Insider trade | 4 | 2026-03-04 | 2026-03-04 |
| Insider trade | 4 | 2026-03-04 | 2026-03-04 |
| Insider trade | 4 | 2026-03-04 | 2026-03-04 |
| Insider trade | 4 | 2026-03-04 | 2026-03-04 |
| Insider trade | 4 | 2026-03-04 | 2026-03-04 |
| Insider trade | 4 | 2026-03-04 | 2026-03-04 |
| Insider trade | 4 | 2026-03-04 | 2026-03-04 |
| Insider trade | 4 | 2026-03-04 | 2026-03-04 |
| Delisting notice | 25-NSE | 2026-03-04 | - |
| S-8 POS | - | 2026-03-04 | - |
| S-8 POS | - | 2026-03-04 | - |
| S-8 POS | - | 2026-03-04 | - |
| S-8 POS | - | 2026-03-04 | - |
| POS AM | - | 2026-03-04 | - |
| POS AM | - | 2026-03-04 | - |
| Major company event | 8-K | 2026-03-04 | 2026-03-04 |
| Insider trade | 4 | 2026-03-03 | 2026-02-27 |
| Major company event | 8-K | 2026-03-03 | 2026-03-03 |
| Proxy materials | DEFA14A | 2026-02-23 | - |
| Major company event | 8-K | 2026-02-23 | 2026-02-23 |
| SCHEDULE 13G | - | 2026-02-19 | - |
| SCHEDULE 13G/A | - | 2026-02-06 | - |
| SCHEDULE 13G | - | 2026-02-05 | - |
| DEFM14A | - | 2026-02-02 | - |
| SCHEDULE 13G/A | - | 2026-01-29 | - |
| PREM14A | - | 2026-01-22 | 2026-01-22 |
| Proxy materials | DEFA14A | 2026-01-22 | - |
| Major company event | 8-K | 2026-01-22 | 2026-01-21 |
| SCHEDULE 13D/A | - | 2026-01-09 | - |
| SCHEDULE 13D/A | - | 2026-01-09 | - |
| Proxy materials | DEFA14A | 2026-01-08 | - |
| Proxy materials | DEFA14A | 2026-01-08 | - |
| Proxy materials | DEFA14A | 2026-01-08 | - |
| Proxy materials | DEFA14A | 2026-01-08 | - |
| Proxy materials | DEFA14A | 2026-01-08 | - |
| Proxy materials | DEFA14A | 2026-01-08 | - |
| Proxy materials | DEFA14A | 2026-01-08 | - |
| Proxy materials | DEFA14A | 2026-01-08 | - |
| Proxy materials | DEFA14A | 2026-01-07 | - |
| Major company event | 8-K | 2026-01-07 | 2026-01-07 |
| Insider trade | 4 | 2025-12-19 | 2025-12-17 |